Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people | Heart

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via BCS

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Article metrics

Special populations

Original research

Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people

Online download statistics by month:

Online download statistics by month: July 2020 to May 2021

	Abstract	Full	Pdf
Jul 2020	83	82	5
Aug 2020	19031	18951	5230
Sep 2020	14894	14841	1847
Oct 2020	13990	13954	1026
Nov 2020	9920	9828	770
Dec 2020	10113	10045	733
Jan 2021	11943	11850	922
Feb 2021	5799	5737	690
Mar 2021	5472	5415	669
Apr 2021	6419	6378	561
May 2021	4634	4618	471
Total	102298	101699	12924